Switch to:
Also traded in: Germany, Mexico, Singapore

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Interest Coverage 43.61
MR's Interest Coverage is ranked lower than
99.99% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.83 vs. MR: 43.61 )
Ranked among companies with meaningful Interest Coverage only.
MR' s Interest Coverage Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 43.61
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MR's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

MR Guru Trades in Q2 2015

Jim Simons 541,900 sh (+5.88%)
Barrow, Hanley, Mewhinney & Strauss Sold Out
Matthews China Fund Sold Out
Frank Sands 477,384 sh (-24.73%)
» More
Q3 2015

MR Guru Trades in Q3 2015

Jim Simons 741,400 sh (+36.81%)
Frank Sands Sold Out
» More
Q4 2015

MR Guru Trades in Q4 2015

Jim Simons 1,705,100 sh (+129.98%)
» More
Q1 2016

MR Guru Trades in Q1 2016

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies  
Compare:SZSE:002414, SZSE:002294, SZSE:300061, SZSE:300171, SZSE:300358, SZSE:300595, SHSE:603222, SHSE:600288, SHSE:603987, SZSE:002432, SZSE:300677, SHSE:603309, SZSE:300246, SZSE:300030, SZSE:300453, SHSE:603880, HKSE:00801, SZSE:300573 » details
Traded in other countries:G2N.Germany, MRN.Mexico, K3QD.Singapore,
Headquarter Location:China
Mindray Medical International Ltd is a developer, manufacturer and marketer of medical devices. The Company has three business segments: patient monitoring & life support products, in-vitro diagnostic products, & medical imaging systems.

Mindray Medical International Ltd was incorporated as an exempted company with limited liability in the Cayman Islands on June 10, 2005 under the Companies Law of the Cayman Islands. The Company is a developer, manufacturer and marketer of medical devices worldwide. The Company operates three primary business segments: patient monitoring and life support products, in-vitro diagnostic products, and medical imaging systems. The Company's patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It currently offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its product line offers customers functionality, such as single- and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that can collect and display multiple patient data on a single screen, and an electro-cardiogram monitoring device. Its multi-parameter monitoring devices can be networked, allowing hospitals to remotely gather patient data from patient rooms and centralize that data in a single location. Its patient monitoring devices also have built-in recorders and have batteries for portability in models, as well as power backup in the event of power failure in mobile models. It also offers a line of veterinary monitoring devices. The Life support products offers anesthesia machines, defibrillators, surgical equipment (including surgical beds and surgical lights ceiling pendants), syringes and infusion pumps, as well as ventilators. The in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. It offers a range of semi-automated and fully-automated in-vitro diagnostic products for laboratories, clinics and hospitals to perform analysis to detect and quantify various substances in the patient samples. Its current product portfolio consists of in-vitro diagnostic products in six product categories: hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products. The hematology analyzers test blood samples to detect abnormalities or foreign substances. The biochemistry analyzers measure the concentration or activity of substances such as enzymes, proteins and substrates. The immunoassay analyzers measure the concentration of protein such as hormone, tumor marker and virus protein. The coagulation analyzers are used to measure activated partial thromboplastin time (APPT), prothrombin time (PT), thrombin time (TT), fibrinogen (FIB), D-Dimer and clotting factor. Urinalysis includes urine sediment and dry chemistry analysis. Urinalysis, together with hematology and biochemistry analysis, are the three common methods used in in

Ratios

vs
industry
vs
history

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.44
MR's Dividend Yield % is ranked higher than
65% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.17 vs. MR: 1.44 )
Ranked among companies with meaningful Dividend Yield % only.
MR' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 1.44
Dividend Payout Ratio 0.27
MR's Dividend Payout Ratio is ranked higher than
60% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. MR: 0.27 )
Ranked among companies with meaningful Dividend Payout Ratio only.
MR' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.27
Forward Dividend Yield % 1.44
MR's Forward Dividend Yield % is ranked higher than
60% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. MR: 1.44 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.44
MR's 5-Year Yield-on-Cost % is ranked higher than
50% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. MR: 1.44 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
MR' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 1.44

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $1,335.85
EPS (TTM) $ 1.49
Short Percentage of Float1.99%
52-Week Range $21.80 - 33.83
Shares Outstanding (Mil)119.79

Analyst Estimate

Dec15 Dec16
Revenue (Mil $) 1,360 1,438
EPS ($) 1.63 1.89
EPS without NRI ($) 1.63 1.89
EPS Growth Rate
(Future 3Y To 5Y Estimate)
3.44%
Dividends per Share ($) 0.26 0.36

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}